Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ejiofor LCK, Mathiesen IHM, Jensen-Fangel S, Olesen HV, et al. Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment. Pediatr Pulmonol 2020;55:3364-3370.
PMID: 32897653


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016